Skip to main content
NYSE:AMRX

Amneal Pharmaceuticals News Headlines

$5.64
+0.16 (+2.92 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.50
$5.65
50-Day Range
$5.20
$6.85
52-Week Range
$3.45
$7.45
Volume725,076 shs
Average Volume1.78 million shs
Market Capitalization$1.69 billion
P/E Ratio13.76
Dividend YieldN/A
Beta1.27

Headlines

Amneal Pharmaceuticals (NYSE AMRX) News Headlines Today

SourceHeadline
Amneal Pharmaceuticals (NYSE:AMRX) Stock Rating Upgraded by TheStreetAmneal Pharmaceuticals (NYSE:AMRX) Stock Rating Upgraded by TheStreet
marketbeat.com - May 6 at 7:15 AM
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q1 2021 Results - Earnings Call TranscriptAmneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 8 at 6:40 PM
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Call TranscriptAmneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Call Transcript
fool.com - May 7 at 6:19 PM
Amneal Pharmaceuticals (NYSE:AMRX)  Shares Down 7.4% Amneal Pharmaceuticals (NYSE:AMRX) Shares Down 7.4%
americanbankingnews.com - May 7 at 3:32 PM
Amneal Reports First Quarter 2021 Financial ResultsAmneal Reports First Quarter 2021 Financial Results
uk.finance.yahoo.com - May 7 at 9:44 AM
Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat EstimatesAmneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates
finance.yahoo.com - May 7 at 9:44 AM
Amneal Pharmaceuticals A earnings preview: what Wall Street is expectingAmneal Pharmaceuticals A earnings preview: what Wall Street is expecting
markets.businessinsider.com - May 5 at 10:36 PM
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Short Interest Up 29.4% in AprilAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Short Interest Up 29.4% in April
americanbankingnews.com - May 3 at 7:18 AM
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q1 Earnings Expected to DeclineEarnings Preview: Amneal Pharmaceuticals (AMRX) Q1 Earnings Expected to Decline
finance.yahoo.com - April 30 at 5:51 PM
Amneal to Report First Quarter 2021 Results on May 7, 2021Amneal to Report First Quarter 2021 Results on May 7, 2021
finance.yahoo.com - April 15 at 8:31 AM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Amneal Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Amneal Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - April 12 at 8:53 AM
Is Amneal Pharmaceuticals, Inc.s (NYSE:AMRX) 19% ROE Strong Compared To Its Industry?Is Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) 19% ROE Strong Compared To Its Industry?
finance.yahoo.com - April 9 at 7:25 AM
Amneal Pharmaceuticals (NYSE:AMRX) Shareholders Have Enjoyed An Impressive 121% Share Price GainAmneal Pharmaceuticals (NYSE:AMRX) Shareholders Have Enjoyed An Impressive 121% Share Price Gain
nasdaq.com - April 7 at 9:18 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Amneal Pharmaceuticals, Inc. (AMRX)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Amneal Pharmaceuticals, Inc. (AMRX)
finance.yahoo.com - March 31 at 2:48 PM
Amneal Posts Better-Than-Expected Q4 Results; Upbeat 2021 Revenue OutlookAmneal Posts Better-Than-Expected Q4 Results; Upbeat 2021 Revenue Outlook
finance.yahoo.com - March 1 at 1:29 PM
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2020 Earnings Call TranscriptAmneal Pharmaceuticals, Inc. (AMRX) Q4 2020 Earnings Call Transcript
fool.com - February 26 at 6:35 PM
Amneal Pharmaceuticals (AMRX) Surpasses Q4 Earnings and Revenue EstimatesAmneal Pharmaceuticals (AMRX) Surpasses Q4 Earnings and Revenue Estimates
nasdaq.com - February 26 at 12:26 PM
A Preview Of Amneal Pharmaceuticalss EarningsA Preview Of Amneal Pharmaceuticals's Earnings
finance.yahoo.com - February 25 at 3:32 PM
Why Amneal Pharmaceuticals (AMRX) Might Surprise This Earnings SeasonWhy Amneal Pharmaceuticals (AMRX) Might Surprise This Earnings Season
msn.com - February 25 at 10:03 AM
Heres what Wall Street expects from Amneal Pharmaceuticals As earningsHere's what Wall Street expects from Amneal Pharmaceuticals A's earnings
markets.businessinsider.com - February 24 at 1:58 PM
Amneal to Virtually Participate at Upcoming Investor ConferencesAmneal to Virtually Participate at Upcoming Investor Conferences
finance.yahoo.com - February 22 at 6:57 PM
Amneal Pharmaceuticals Inc Registered Shs -A- hosts conference call for investorsAmneal Pharmaceuticals Inc Registered Shs -A- hosts conference call for investors
markets.businessinsider.com - February 19 at 2:10 PM
Amneal Pharmaceuticals, Inc.s (NYSE:AMRX) Intrinsic Value Is Potentially 96% Above Its Share PriceAmneal Pharmaceuticals, Inc.'s (NYSE:AMRX) Intrinsic Value Is Potentially 96% Above Its Share Price
finance.yahoo.com - February 8 at 7:36 AM
Amneal to Report Fourth Quarter & Full Year 2020 Results on February 26, 2021Amneal to Report Fourth Quarter & Full Year 2020 Results on February 26, 2021
finance.yahoo.com - February 4 at 11:36 AM
AMRX or PCRX: Which Is the Better Value Stock Right Now?AMRX or PCRX: Which Is the Better Value Stock Right Now?
finance.yahoo.com - January 15 at 2:32 PM
Amneal Pharma Announces Acquisition Of Kashiv Specialty - Quick FactsAmneal Pharma Announces Acquisition Of Kashiv Specialty - Quick Facts
nasdaq.com - January 12 at 10:17 AM
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg,Following ANDA Approval by FDAAmneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg,Following ANDA Approval by FDA
marketwatch.com - January 9 at 9:21 AM
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDAAmneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA
finance.yahoo.com - January 8 at 12:58 PM
Amneal to Virtually Participate at the 39th Annual J.P. Morgan Healthcare ConferenceAmneal to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 9:36 AM
Recent Challenges Demand Innovative Approaches to Surface DisinfectionsRecent Challenges Demand Innovative Approaches to Surface Disinfections
finanznachrichten.de - December 19 at 12:32 AM
21 Largest Generic Drug Companies21 Largest Generic Drug Companies
finance.yahoo.com - December 16 at 2:39 PM
Amneal Analyst: Pharma Well-Positioned Ahead Of 2021 Generic LaunchesAmneal Analyst: Pharma Well-Positioned Ahead Of 2021 Generic Launches
benzinga.com - December 14 at 5:39 PM
Is AMRX A Good Stock To Buy Now?Is AMRX A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 11:04 PM
Is Amneal Pharmaceuticals (AMRX) a Good Stock to Pick Now?Is Amneal Pharmaceuticals (AMRX) a Good Stock to Pick Now?
msn.com - November 16 at 2:55 PM
Is Amneal Pharmaceuticals (AMRX)  a Good Stock to Pick Now?Is Amneal Pharmaceuticals (AMRX) a Good Stock to Pick Now?
finance.yahoo.com - November 16 at 2:55 PM
FDA OKs Amneal Pharmaceuticals Acyclovir creamFDA OKs Amneal Pharmaceuticals' Acyclovir cream
seekingalpha.com - November 11 at 12:57 PM
Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5%Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5%
finance.yahoo.com - November 11 at 12:57 PM
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Third-Quarter Results: Heres What Analysts Are Forecasting For Next YearAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
nasdaq.com - November 10 at 7:58 AM
The Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Third-Quarter Results Are Out And Analysts Have Published New ForecastsThe Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
finance.yahoo.com - November 10 at 7:58 AM
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2020 Earnings Call TranscriptAmneal Pharmaceuticals, Inc. (AMRX) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 6 at 10:55 PM
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2020 Results - Earnings Call TranscriptAmneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 5:54 PM
Amneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Top EstimatesAmneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Top Estimates
finance.yahoo.com - November 6 at 12:53 PM
Recap: Amneal Pharmaceuticals Q3 EarningsRecap: Amneal Pharmaceuticals Q3 Earnings
finance.yahoo.com - November 6 at 12:53 PM
Amneal Pharmaceuticals EPS beats by $0.04, beats on revenueAmneal Pharmaceuticals EPS beats by $0.04, beats on revenue
seekingalpha.com - November 6 at 7:53 AM
Amneal Reports Third Quarter 2020 Financial ResultsAmneal Reports Third Quarter 2020 Financial Results
businesswire.com - November 6 at 7:53 AM
Amneal Pharmaceuticals Q3 2020 Earnings PreviewAmneal Pharmaceuticals Q3 2020 Earnings Preview
seekingalpha.com - November 5 at 3:01 PM
Earnings Outlook for Amneal PharmaceuticalsEarnings Outlook for Amneal Pharmaceuticals
finance.yahoo.com - November 5 at 3:01 PM
Should You Buy Amneal (AMRX) Ahead of Earnings?Should You Buy Amneal (AMRX) Ahead of Earnings?
finance.yahoo.com - November 5 at 10:00 AM
Amneal Pharmaceuticals IncAmneal Pharmaceuticals Inc
bloomberg.com - October 30 at 7:29 PM
Amneal Pharmaceuticals (AMRX) Reports Next Week: Wall Street Expects Earnings GrowthAmneal Pharmaceuticals (AMRX) Reports Next Week: Wall Street Expects Earnings Growth
finance.yahoo.com - October 30 at 2:29 PM
Why Amneal (AMRX) is Poised to Beat Earnings Estimates AgainWhy Amneal (AMRX) is Poised to Beat Earnings Estimates Again
finance.yahoo.com - October 22 at 12:54 PM
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.